The Masonic Cancer Center's clinical partner is University of Minnesota Health. Visit mhealth.org/cancer to find information about cancer care, providers, and cancer clinic locations.
Cancer Information Nurse Line
Reach a nurse specializing in cancer care, Monday through Friday from 8 a.m. to 4:30 p.m.
New cancer treatments must prove to be safe and effective in scientific studies with a certain number of patients before they can be made widely available. Through clinical trials, researchers learn which approaches are more effective than others.
Our Research Focus
The Masonic Cancer Center brings together scientists from different disciplines to discover processes that affect cancer. It is home to state-of-the-art research tools and some of the world's top cancer researchers in:
MINNEAPOLIS, MN- August 13, 2020 - A patient with COVID-19 and lung failure at the University of Minnesota is the first to be treated in the U.S. on a new FDA-approved clinical trial determining the safety and effectiveness of mesenchymal stem cells (MSCs).
MINNEAPOLIS, MN- August 6, 2020 - The first patient has received treatment in a new clinical trial that has opened at the University of Minnesota to test whether a novel cell therapy currently under clinical investigation as a treatment for acute myeloid leukemia (AML) and lymphoma can be effective as a treatment for COVID-19. The first-of-its-kind, engineered iPSC-derived natural killer (NK) cell product candidate, FT516, may play a role in diminishing viral replication of the novel coronavirus.